Epithelial Ovarian Cancer: A Five Year Review
نویسندگان
چکیده
Ovarian cancer is a malignant disease that affects thousands of patients every year. Currently, we use surgical techniques for early-stage and chemotherapy treatment combinations advanced stage cancer. Several novel therapies are currently being investigated, with gene therapy stem cell the corner stone this investigation. We conducted thorough search on PubMed gathered up-to-date information regarding epithelial ovarian therapies. present, in current review, all treatments were investigated field over past five years, particular focus local treatment.
منابع مشابه
Epithelial ovarian cancer stem cells-a review.
Ovarian cancer is the fifth leading cause of cancer deaths among women and the most common type of gynecologic malignancy. Despite advances in surgery and chemotherapy, the survival rate of patients with epithelial ovarian cancer is still low. For a whole decade, that situation has not improved. Most ovarian cancer patients relapse and become drug-resistant. Increasing evidence has suggested th...
متن کاملTreatment and prognosis of epithelial ovarian cancer: five year multi-center study.
OBJECTIVE To study the response rate for common chemotherapy regimens, and the progression free survival analysis in ovarian cancer in Tehran. METHODS Ninety-eight women with confirmed ovarian cancer who had surgery, followed by chemotherapy at the 3 hospitals in (Fayazbakhsh, Shohadayee Tajrish, and Imam-Hossein), Tehran, Iran, between 1997 and 2003 were enrolled in this retrospective descri...
متن کاملREVIEW Possible Role of Ovarian Epithelial Inflammation in Ovarian Cancer
Ovarian cancer is a commonly fatal disease for which prevention strategies have been limited, in part because of a lack of understanding of the underlying biology. This paper reviews the epidemiologic literature in the English language on risk factors and protective factors for ovarian cancer and proposes a novel hypothesis that a common mechanism underlying this disease is inflammation. Previo...
متن کاملTen-year relative survival for epithelial ovarian cancer.
OBJECTIVE Most patients with epithelial ovarian cancer who are alive at 5 years have active disease. Thus, 10-year survival rather than 5-year survival may be a more appropriate endpoint. Relative survival adjusts for the general survival of the United States population for that race, sex, age, and date at which the diagnosis was coded. Our objective was to estimate relative survival in epithel...
متن کاملepigenetic brca2 gene in epithelial ovarian cancer
background ovarian cancer is the most common fatal gynecologic malignancy in women. the brca2 gene has a role in regulation of cell cycle during proliferation, differentiation and dna repair. changes in the methylation of brca2 may be an effective mechanism for ovarian cancer. objectives the aim of the present study was to evaluate the association between ovarian cancer and methylation status o...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Medicina-lithuania
سال: 2023
ISSN: ['1010-660X', '1648-9144']
DOI: https://doi.org/10.3390/medicina59071183